MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Early Indicators of Alpha-synuclein Aggregation: Can Autonomic and Cognitive Markers Predict Prodromal Parkinson’s Disease?

    B. Kansu, C. Mattjie, R. Ravazio, M. Patyjewicz, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To develop a model that predicts alpha synuclein (a-syn) status of patients at risk of Parkinson’s disease (PD) using non-motor and cognitive tests that…
  • 2025 International Congress

    Safety and tolerability of overnight switching from Eetacapone to Opicapone in fluctuating Parkinson’s disease: An open-label preliminary trial in Koreans

    M. Park, J. An (Daegu, Republic of Korea)

    Objective: Objectives: 1. Efficacy - Opicapone 50mg qd. to determine effectiveness of optimal dose for switching. 2. Tolerability and safety - compare symptoms and adverse…
  • 2025 International Congress

    A Comparative Analysis of Water-Based versus Land-Based Exercise Interventions for Improving Quality of Life in Parkinson’s Disease: A Systematic Review

    S. A. Hassan, A. Abdelsalhin, M. Mustafa, N. Elmestkawy, O. Hafez, N. Abdeltawab, M. M. Elsayed (Giza, Egypt)

    Objective: To compare the effectiveness of water-based and land-based exercise interventions in improving quality of life (QoL) and motor function in individuals with Parkinson’s disease…
  • 2025 International Congress

    Supporting Movement Disorders Specialists with Digital Tools that Integrate with their Workflows

    J. Ikhile, V. Pandey (Salt Lake City, USA)

    Objective: Our work investigates how to design digital tools to assist movement disorders specialists in their clinical work. Background: Digital tools are ubiquitous in healthcare;…
  • 2025 International Congress

    Frequency of Falls in the Parkinson’s Progression Markers Initiative

    J. Vizcarra, D. Lafontant, A. Siderowf (Philadelphia, USA)

    Objective: To determine the faller rate across years since diagnosis and neuronal α-synuclein disease integrated staging system (NSD-ISS) stages in the Parkinson's Progression Markers Initiative…
  • 2025 International Congress

    Helicobacter Pylori Infection, Peptic Ulcer, Gastritis and Risk of Parkinson´s Disease: a Nationwide Matched Cohort Study

    S. Licaj, A. Ploner, A. Szwajda, S. Hägg, F. Fang, J. Ludvigsson, K. Wirdefeldt (Solna, Sweden)

    Objective: To examine the potential link between H. pylori infection, gastritis, peptic ulcer and Parkinson’s Disease (PD) risk. Background: Gastrointestinal disorders are frequent among PD…
  • 2025 International Congress

    The Impact of Socioeconomic Status on Functionality in people with Parkinson’s Disease

    A. Paixão, N. Pereira, R. Luz, E. Oliveira, I. Chaves, G. Vanucci, M. Piemonte (São Paulo, Brazil)

    Objective: To investigate the impact of socioeconomic status (SES) on functionality in people with Parkinson's disease (PD) using the World Health Organization Disability Assessment Schedule…
  • 2025 International Congress

    Early Impairment in the Immunomodulatory Function of Mesenchymal Stromal Cells Contributes to Heightened Peripheral and Neuroinflammation in Parkinson’s Disease Insights From In Vivo Chronic PD Rat Model and In Vitro PD iPSC Model

    R. Ghanty, I. Datta, G. Wagmare, N. Kamble, PK. Pal, V. Holla, R. Yadav, K. Mondal (Bengaluru, India)

    Objective: To assess the timeline dependent changes in endogenous Bone-Marrow-Mesenchymal-Stromal-Cells (BMMSC) in in-vivo chronic PD model and validating these cellular modifications in human iPSC derived…
  • 2025 International Congress

    The Impact of Microgravity and Herpes Simplex Virus 1 on Parkinson’s Neurodegeneration and HERV Expression

    ER. Simula, S. Jasemi, D. Cossu, I. Cossu, M. Fais, M. Noli, LA. Sechi (Sassari, Italy)

    Objective: The present abstract aims to investigate the impact of viral infections and microgravity exposure in the context of Parkinson’s disease (PD). Background: PD is…
  • 2025 International Congress

    Decoding Parkinson’s Progression: Longitudinal Volumetric MRI Biomarkers in Prodromal and Clinical Stages

    S. Datta, M. Acharya, N. Ghosh, B. Chakraborty (Kharagpur, India)

    Objective: This study investigates MRI volumetric analysis via VBM as a biomarker for early PD detection, focusing on structural alterations in deep gray matter regions…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley